About: The onset of effect of the H1-antagonist acrivastine ("Semprex") assessed by histamine bronchial challenge in volunteers

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The onset of effect of the H1-antagonist acrivastine ("Semprex") assessed by histamine bronchial challenge in volunteers Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1990

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1990 (uk) im Januar 1990 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1990 (ast) artikull shkencor i botuar më 01 janar 1990 (sq) scientific article published on 01 January 1990 (en)
publication date	wds:Q68163726-D8504A52-AF76-4420-A8E9-CAF450959AE4
publication date	1990-01-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q68163726-99A235F2-5AE2-424E-B06C-A28E0754E83A
exact match	https://scigraph.springernature.com/pub.10.1007/bf00315119
cites work	wds:Q68163726-5ACAB5A6-FAF9-434A-A126-7A49737E94B5 wds:Q68163726-9CE45097-FFE1-4A7F-94F7-B04C2B06CB37 wds:Q68163726-A75ECBCA-CCE0-4CD4-9985-09426043D9C5 wds:Q68163726-C4BEDD1A-00CC-413A-A883-7530A80AB86E wds:Q68163726-E340C81B-4A31-446A-8DEE-AE51203567DB wds:Q68163726-E65765D2-6B79-47C1-A425-F0301B28A4C7 wds:Q68163726-FAFA2FCA-C42F-4629-92A1-2C305355A650 wds:Q68163726-FF6DC220-6E57-4F8F-ACD2-439B5231D063
cites work	Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy The effects of H1 and H2 antihistamines on histamine inhalation challenges in asthmatic patients Bronchial reactivity to inhaled histamine: a method and clinical survey Pharmacokinetics and biotransformation studies of terfenadine in man Terfenadine (Seldane) is a potent and selective histamine H1 receptor antagonist in asthmatic airways Comparison of the onset of H1-antagonism with acrivastine and terfenadine by histamine bronchial challenge in volunteers Pharmacodynamic and pharmacokinetics of BW 825C: a new antihistamine Partial flow-volume curves
author name string	wds:Q68163726-9C82E534-2F8E-4F56-81A3-77F831E5C518 wds:Q68163726-CF118323-20B5-47C6-94DB-61B33D9764A6 wds:Q68163726-E54CCCEB-E62B-464C-A722-69AEC5302E52 wds:Q68163726-F6CEA01A-D9A6-4259-A4E9-1AF0E81BC674
author name string	S Phillips J Adams J Posner P E Rolan
rdfs:label	The onset of effect of the H1-antagonist acrivastine ("Semprex") assessed by histamine bronchial challenge in volunteers (en) The onset of effect of the H1-antagonist acrivastine ("Semprex") assessed by histamine bronchial challenge in volunteers (sq) The onset of effect of the H1-antagonist acrivastine (nl)
skos:prefLabel	The onset of effect of the H1-antagonist acrivastine ("Semprex") assessed by histamine bronchial challenge in volunteers (en) The onset of effect of the H1-antagonist acrivastine ("Semprex") assessed by histamine bronchial challenge in volunteers (sq) The onset of effect of the H1-antagonist acrivastine (nl)
name	The onset of effect of the H1-antagonist acrivastine ("Semprex") assessed by histamine bronchial challenge in volunteers (en) The onset of effect of the H1-antagonist acrivastine ("Semprex") assessed by histamine bronchial challenge in volunteers (sq) The onset of effect of the H1-antagonist acrivastine (nl)
title	wds:Q68163726-D787D6F2-F411-48E7-85DE-2331BB0473EF
title	The onset of effect of the H1-antagonist acrivastine ("Semprex") assessed by histamine bronchial challenge in volunteers (en)
page(s)	wds:Q68163726-A748B74D-2C7B-49A5-A7F1-91B54C65B524
page(s)	311-313
instance of	wds:Q68163726-50802E41-190F-4CC0-860C-576024B0AFD9
instance of	scholarly article
PubMed ID	wds:Q68163726-BA5E91A8-1184-4EC9-82EC-43382BDF66F8
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1979541
PubMed ID	1979541
published in	wds:Q68163726-CF3A4984-FD25-4ED8-8699-8742FDAAE053
published in	European Journal of Clinical Pharmacology
issue	wds:Q68163726-D6593430-84B4-4227-94B6-C29DDD83999A
volume	wds:Q68163726-01BF278E-0EF1-456A-BD5F-D8E79A72EA15
issue	3
volume	39
DOI	wds:Q68163726-1F1AD85E-592D-41FB-BCA8-3B93F1C8D545
DOI	http://dx.doi.org/10.1007/BF00315119
DOI	10.1007/BF00315119
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q68163726
is cites work of	Acrivastine. A review of its pharmacological properties and therapeutic efficacy in allergic rhinitis, urticaria and related disorders
is cites work of	wds:Q36676445-8EA0C7FF-0302-4CCE-A676-7302454008B2

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software